Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2017, ended Dec 31, 2017 | — |
| FY2018, ended Dec 31, 2018 | — |
| FY2019, ended Dec 31, 2019 | $40.6B |
| FY2020, ended Dec 31, 2020 | $41.3B |
| FY2021, ended Dec 31, 2021 | $41.7B |
| FY2022, ended Dec 31, 2022 | $35.5B |
| FY2023, ended Dec 31, 2023 | $38.5B |
| FY2024, ended Dec 31, 2024 | $28.2B |
| FY2025, ended Dec 31, 2025 | $16.8B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $19.9B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2017, ended Dec 31, 2017 | $43.7B |
| FY2018, ended Dec 31, 2018 | $49.6B |
| FY2019, ended Dec 31, 2019 | $43.0B |
| FY2020, ended Dec 31, 2020 | $38.5B |
| FY2021, ended Dec 31, 2021 | $55.0B |
| FY2022, ended Dec 31, 2022 | $56.9B |
| FY2023, ended Dec 31, 2023 | $44.6B |
| FY2024, ended Dec 31, 2024 | $43.0B |
| FY2025, ended Dec 31, 2025 | $40.0B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $42.6B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2017, ended Dec 31, 2017 | $465M | −$7.74B |
| FY2018, ended Dec 31, 2018 | $4.64B | $2.16B |
| FY2019, ended Dec 31, 2019 | −$1.36B | $3.97B |
| FY2020, ended Dec 31, 2020 | $1.23B | $4.97B |
| FY2021, ended Dec 31, 2021 | $6.31B | $5.51B |
| FY2022, ended Dec 31, 2022 | $4.58B | $5.65B |
| FY2023, ended Dec 31, 2023 | $589M | $2.84B |
| FY2024, ended Dec 31, 2024 | $1.12B | −$26.0M |
| FY2025, ended Dec 31, 2025 | −$2.62B | −$1.45B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | −$897M | — |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2017, ended Dec 31, 2017 | $6.19B |
| FY2018, ended Dec 31, 2018 | $2.72B |
| FY2019, ended Dec 31, 2019 | $2.37B |
| FY2020, ended Dec 31, 2020 | $5.10B |
| FY2021, ended Dec 31, 2021 | $2.99B |
| FY2022, ended Dec 31, 2022 | $3.89B |
| FY2023, ended Dec 31, 2023 | $2.99B |
| FY2024, ended Dec 31, 2024 | $2.19B |
| FY2025, ended Dec 31, 2025 | $3.82B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $4.14B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2017, ended Dec 31, 2017 | — |
| FY2018, ended Dec 31, 2018 | $19.9B |
| FY2019, ended Dec 31, 2019 | $17.0B |
| FY2020, ended Dec 31, 2020 | $17.1B |
| FY2021, ended Dec 31, 2021 | $14.7B |
| FY2022, ended Dec 31, 2022 | $15.4B |
| FY2023, ended Dec 31, 2023 | $15.1B |
| FY2024, ended Dec 31, 2024 | $16.2B |
| FY2025, ended Dec 31, 2025 | $18.1B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $17.5B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 2.8% since FY17.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2017, ended Dec 31, 2017 | 745M |
| FY2018, ended Dec 31, 2018 | 749M |
| FY2019, ended Dec 31, 2019 | 742M |
| FY2020, ended Dec 31, 2020 | 744M |
| FY2021, ended Dec 31, 2021 | 736M |
| FY2022, ended Dec 31, 2022 | 705M |
| FY2023, ended Dec 31, 2023 | 702M |
| FY2024, ended Dec 31, 2024 | 704M |
| FY2025, ended Dec 31, 2025 | 718M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 724M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2017, ended Dec 31, 2017 | $0 | $310M | $66.0M |
| FY2018, ended Dec 31, 2018 | $0 | $188M | $112M |
| FY2019, ended Dec 31, 2019 | $500M | $158M | $93.0M |
| FY2020, ended Dec 31, 2020 | $125M | $171M | $108M |
| FY2021, ended Dec 31, 2021 | $1.00B | $276M | $320M |
| FY2022, ended Dec 31, 2022 | $2.33B | $211M | $212M |
| FY2023, ended Dec 31, 2023 | $625M | $212M | $188M |
| FY2024, ended Dec 31, 2024 | $494M | $159M | $166M |
| FY2025, ended Dec 31, 2025 | $0 | $154M | $85.0M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | — | — | — |
Valuation
At current price- Market Cap
- $24.5B
- P/E
- n/m. Market cap / net income (TTM)
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 0.6×
- Price / Book
- 1.5×
- EV / EBITDA
- 11.9×
Growth
Trailing 12 months- Revenue (TTM)
- $42.6B
- Revenue Growth YoY
- 4.2%
- Revenue CAGR 3Y
- −11.1%
- Revenue CAGR 5Y
- 0.7%
- EPS Growth YoY
- n/m. Diluted EPS, TTM vs. TTM a year earlier
- Net Income Growth YoY
- n/m. TTM vs. TTM a year earlier
Profitability
Trailing 12 months- Gross Margin
- 11.1%
- Operating Margin
- —
- Net Margin
- −2.1%
- FCF Margin
- —. Free cash flow / revenue
- Return on Equity
- −5.3%
Earnings
Trailing 12 months- Net Income
- −$897M
- EPS (diluted)
- −$1.29
- EBITDA
- $3.19B
- Operating Income
- —
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $4.14B
- Total Debt
- $17.5B
- Net Debt
- $13.4B
- Total Assets
- $61.0B
- Total Liabilities
- $43.3B
- Shareholders' Equity
- $16.2B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $4.58B
- Capital Expenditure
- —
- Free Cash Flow
- —. Operating cash flow − capital expenditure
Dividends and risk
Last 12 months- Dividend Yield
- 4.1%
- Dividend / Share
- $1.40
- Beta (5Y)
- 0.43
Every ratio is calculated from the company’s reported figures.